FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * KINDERHOOK, LP   2. Issuer Name and Ticker or Trading Symbol NEOGENOMICS INC [NGNM] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner _____ Officer (give title below) __X__ Other (specify below) See Remarks (Last) (First) (Middle) TWO EXECUTIVE DRIVE, SUITE 585 3. Date of Earliest Transaction (Month/Day/Year) 05/13/2013 (Street) FORT LEE, NJ 07024 4. If Amendment, Date Original Filed(Month/Day/Year) 6. Individual or Joint/Group Filing(Check Applicable Line) ___ Form filed by One Reporting Person _X_ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code (Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date (Month/Day/Year)

7. Title and Amount of Underlying Securities (Instr. 3 and 4)

8. Price of Derivative Security (Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)

11. Nature of Indirect Beneficial Ownership (Instr. 4)

Code

V

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
KINDERHOOK, LP TWO EXECUTIVE DRIVE SUITE 585 FORT LEE, NJ 07024				See Remarks
KINDERHOOK GP LLC TWO EXECUTIVE DRIVE SUITE 585 FORT LEE, NJ 07024				See Remarks
KINDERHOOK PARTNERS, LLC TWO EXECUTIVE DRIVE SUITE 585 FORT LEE, NJ 07024				See Remarks
Shah Tushar TWO EXECUTIVE DRIVE SUITE 585 FORT LEE, NJ 07024				See Remarks
CLEARMAN STEPHEN J TWO EXECUTIVE DRIVE SUITE 585 FORT LEE, NJ 07024				See Remarks

Signatures

/s/ Tushar Shah, Managing Member of Kinderhook, LP's General Partner		07/19/2013
**Signature of Reporting Person		Date
/s/ Tushar Shah, Managing Member of Kinderhook GP, LLC		07/19/2013
**Signature of Reporting Person		Date
/s/ Tushar Shah, Managing Member of Kinderhook Partners, LLC		07/19/2013
**Signature of Reporting Person		Date
/s/ Tushar Shah		07/19/2013
**Signature of Reporting Person		Date
/s/ Stephen J. Clearman		07/19/2013
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Remarks: On May 13, 2013, Neogenomics, Inc. filed Form 10-Q for the quarter ending March 31, 2013, which reported that as of May 6, 2013, Neogenomics had 48,704,038 shares of Common Stock with a par value $0.001 per share outstanding.  Based on Neogenomic's reported shares outstanding as of May 13, 2013, Kinderhook, LP; Kinderhook GP, LLC; Kinderhook Partners, LLC; Tushar Shah; and Stephen J. Clearman were no longer the beneficial owners, directly or indirectly, of more than ten percent of any class of Neogenomic's equity securities registered pursuant to Section 12 of the U.S. Securities Exchange Act of 1934.  Mr. Tushar Shah; Mr. Stephen J. Clearman, Kinderhook Partners, LLC; Kinderhook GP, LLC; and Kinderhook, LP disclaim beneficial ownership of the shares of Neogenomics Common Stock except to the extent of his or its respective pecuniary interest, if any, therein.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.